Pro zobrazení tohoto obsahu je třeba být přihlášen.
Categories for Uncategorized
Pozoruhodnosti o AML na EHA© 2019
15 septembra, 2020 7:11 pm24. kongres Európskej hematologickej asociácie (EHA) sa konal tento rok 13. – 16. júna v holandskom Amsterdame. Kongres navštívilo rekordných 12 000...
RESULTS OF A PROSPECTIVE MULTICENTER STUDY ON PRO-ATHEROTHROMBOTIC EFFECT INDUCED BY TYROSINE-KINASE INHIBITORS FOR FIRST-LINE TREATMENT OF CML PTS (KIARO TRIAL)
15 septembra, 2020 7:11 pmAuthor(s): Anna Sicuranza, Corrado Zuanelli Brambilla, Ilaria Ferrigno, et. al. EHA Library. Sicuranza A. Jun 14, 2019; 266220; PF420 ...
DURABILITY AND IMPACT ON QUALITY OF LIFE OF TREATMENT-FREE REMISSION (TFR) IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) AFTER STOPPING FRONTLINE (1L) NILOTINIB: ENESTFREEDOM 192-WK RESULTS
15 septembra, 2020 7:11 pmAuthor(s): David M. Ross, Tamas Masszi, María Teresa, et. al. EHA Library. Ross D. Jun 14, 2019; 266209; PF409 ...
TREATMENT-FREE REMISSION IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA FOLLOWING FIRST-LINE DASATINIB, 1ST DADI/IMIDAS4
15 septembra, 2020 7:11 pmAuthor(s): Kazunori Murai, Shinya Kimura, Jun Imagawa, et. al. EHA Library. MURAI K. Jun 14, 2019; 266207; PF407 Abstract:...
OPTIMIZATION OF TKI TREATMENT IN ELDERLY PATIENTS
15 septembra, 2020 7:11 pmAuthor(s): Michele Malagola, Fabio Efficace, Nicola Polverelli, et. al. EHA Library. malagola M. Jun 15, 2019; 267465; S882 Abstract:...
CHRONICKÁ MYELOCYTOVÁ LEUKÉMIA – NOVINKY Z KONGRESU EURÓPSKEJ HEMATOLOGICKEJ ASOCIÁCIE 2019
15 septembra, 2020 7:11 pmChronická myelocytová leukémia (CML) je klonálna myeloproliferatívna neoplázia charakterizovaná prítomnosťou BCR/ABL fúzneho génu. Od roku 2001 sa zavedením inhibítora tyrozínkinázy...
CHANGE IN CLONE SIZE DOES NOT PREDICT RISK OF MAJOR ADVERSE VASCULAR EVENTS: RESULTS FROM THE INTERNATIONAL PNH REGISTRY
15 septembra, 2020 7:11 pmAuthor(s): Régis Peffault de Latour, Austin Kulasekararaj, Loree Larratt, et. al. EHA Library. Gustovic P. Jun 15, 2019; 267448; S865...
ABSENCE OF GPI-NEGATIVE CELLS AT DIAGNOSIS AND LOW NEUTROPHIL COUNT 2 MONTHS AFTER ATGAM BASED TREATMENT ARE ASSOCIATED WITH LOWER 6-MONTH RESPONSE RATE IN ADULTS WITH (VERY) SEVERE APLASTIC ANEMIA
15 septembra, 2020 7:11 pmAuthor(s): Jennifer Tjon, Lisette Bogers, Liesbeth de Wreede, et. al. EHA Library. Tjon J. Jun 15, 2019; 266738; PS1121 ...
INHIBITION OF C3 WITH APL-2 CONTROLS HAEMOLYSIS AND INCREASES HAEMOGLOBIN LEVELS IN SUBJECTS WITH AUTOIMMUNE HAEMOLYTIC ANAEMIA (AIHA)
15 septembra, 2020 7:11 pmAuthor(s): Morie Gertz, Eloy Roman, Bruno Fattizzo, et. al. EHA Library. Fattizzo B. Jun 15, 2019; 267482; S899 Abstract:...
A PHASE 2 OPEN-LABEL PROOF OF CONCEPT STUDY OF THE ORAL, SMALL MOLECULE FACTOR D INHIBITOR, ACH-4471, IN UNTREATED PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)
15 septembra, 2020 7:11 pmAuthor(s): Peter Browett, Austin Kulasekararaj, Jong Wook Lee, et. al. EHA Library. Browett P. Jun 15, 2019; 267447; S864 ...